Cutting Edge: Selective Role of Ubiquitin in MHC Class I Antigen Presentation

被引:22
作者
Huang, Lan [1 ]
Marvin, Julie M. [1 ]
Tatsis, Nia [1 ]
Eisenlohr, Laurence C. [1 ]
机构
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
ENDOPLASMIC-RETICULUM; DEGRADATION SIGNAL; ACTIVATING ENZYME; MAMMALIAN-CELLS; VACCINIA VIRUS; AAA-ATPASE; PROTEIN; EXPRESSION; PROTEASOME; EPITOPE;
D O I
10.4049/jimmunol.1003411
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of ubiquitination in MHC class I-restricted Ag processing remains unclear. To address this issue, we overexpressed wild-type and dominant-negative lysineless forms of ubiquitin (Ub) in mammalian cells using an inducible vaccinia virus system. Overexpression of the lysineless Ub nearly abrogated polyubiquitination and potently inhibited epitope presentation from a cytosolic N-end rule substrate as well as endoplasmic reticulum (ER)-targeted model Ags. In contrast, there was little impact on Ag presentation from cytosolic proteins. These trends were location dependent; redirecting cytosolic Ag to the ER rendered presentation lysineless Ub-sensitive, whereas retargeting exocytic Ag to the cytosol had the inverse effect. This dichotomy was further underscored by small interfering RNA knockdown of the ER-associated Ub ligase Hrd1. Thus, Ub-dependent degradation appears to play a major role in the MHC class I-restricted processing of ER-targeted proteins and a more restricted role in the processing of cytosolic proteins. The Journal of Immunology, 2011, 186: 1904-1908.
引用
收藏
页码:1904 / 1908
页数:5
相关论文
共 50 条
  • [21] The proteasorne and MHC class I antigen processing
    Kloetzel, PM
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3): : 225 - 233
  • [22] Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis
    Teoh, CY
    Davies, KJA
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2004, 423 (01) : 88 - 96
  • [23] Causal ALS genes impact the MHC class II antigen presentation pathway
    Chi, Binkai
    Oztuerk, Muhammet M.
    Paraggio, Christina L.
    Leonard, Claudia E.
    Sanita, Maria E.
    Dastpak, Mahtab
    O'Connell, Jeremy D.
    Coady, Jordan A.
    Zhang, Jiuchun
    Gygi, Steven P.
    Lopez-Gonzalez, Rodrigo
    Yin, Shanye
    Reed, Robin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (39)
  • [24] Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer
    Demel, Uta M.
    Boeger, Marlitt
    Yousefian, Schayan
    Grunert, Corinna
    Zhang, Le
    Hotz, Paul W.
    Gottschlich, Adrian
    Koese, Hazal
    Isaakidis, Konstandina
    Vonficht, Dominik
    Gruenschlaeger, Florian
    Rohleder, Elena
    Wagner, Kristina
    Doenig, Judith
    Igl, Veronika
    Brzezicha, Bernadette
    Baumgartner, Francis
    Habringer, Stefan
    Loeber, Jens
    Chapuy, Bjoern
    Weidinger, Carl
    Kobold, Sebastian
    Haas, Simon
    Busse, Antonia B.
    Mueller, Stefan
    Wirth, Matthias
    Schick, Markus
    Keller, Ulrich
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (09)
  • [25] Autophagy Beyond Intracellular MHC Class II Antigen Presentation
    Muenz, Christian
    TRENDS IN IMMUNOLOGY, 2016, 37 (11) : 755 - 763
  • [26] Comment on "Cutting Edge: FcR-Like 6 Is an MHC Class II Receptor"
    Huard, Bertrand
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09) : 4965 - 4965
  • [27] Presentation of Phagocytosed Antigens by MHC Class I and II
    Mantegazza, Adriana R.
    Magalhaes, Joao G.
    Amigorena, Sebastian
    Marks, Michael S.
    TRAFFIC, 2013, 14 (02) : 135 - 152
  • [28] Cutting Edge: Limited Specialization of Dendritic Cell Subsets for MHC Class II-Associated Presentation of Viral Particles
    Keller, Susanne A.
    Bauer, Monika
    Manolova, Vania
    Muntwiler, Simone
    Saudan, Philippe
    Bachmann, Martin F.
    JOURNAL OF IMMUNOLOGY, 2010, 184 (01) : 26 - 29
  • [29] Role of tripeptidyl peptidase II in MHC class I antigen processing - the end of controversies?
    van Endert, Peter
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (03) : 609 - 613
  • [30] Vaccinia virus A35R inhibits MHC class II antigen presentation
    Rehm, Kristina E.
    Connor, Ramsey F.
    Jones, Gwendolyn J. B.
    Yimbu, Kenneth
    Roper, Rachel L.
    VIROLOGY, 2010, 397 (01) : 176 - 186